Loading...
XNSE
FDC
Market cap685mUSD
Nov 12, Last price  
407.20INR
Name

F D C Ltd

Chart & performance

D1W1MN
XNSE:FDC chart
P/E
23.56
P/S
3.05
EPS
17.29
Div yield, %
—
Shrs. gr., 5y
-0.86%
Rev. gr., 5y
10.35%
Revenues
21.71b
+2.98%
4,314,724,0004,951,231,0005,891,307,0006,614,582,0007,076,094,0007,105,408,0007,700,309,0008,425,534,0008,867,123,00010,012,247,00010,089,576,00010,704,743,00010,848,904,00013,374,192,00013,268,276,00015,257,457,00017,837,502,00019,351,996,00021,081,204,00021,709,332,000
Net income
2.81b
+5.49%
656,139,000631,689,000862,093,0001,491,304,0001,508,903,0001,340,880,0001,551,705,0001,353,184,0001,481,454,0001,566,168,0001,885,320,0001,735,091,0001,697,888,0002,398,784,0003,013,456,0002,164,033,0001,940,374,0003,052,233,0002,667,881,0002,814,216,000
CFO
2.49b
-31.66%
648,431,000936,703,000881,193,0001,681,645,0001,213,538,0001,420,733,0001,499,403,0001,484,846,0001,197,957,0001,747,630,0001,533,223,0001,498,430,0001,124,288,0002,503,806,0002,070,815,0001,616,522,0001,549,131,0002,207,674,0003,641,577,0002,488,544,000
Dividend
Feb 11, 20265 INR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.

Key people

Vijay Bhatt
Chief Financial Officer · since 2023
Vishal Shah
Chief Financial Officer · since 2025
Mohan Chandavarkar
Managing Director, Executive Director · since 2019
Ashok Chandavarkar
Executive Director · since 1987
Nandan Chandavarkar
Joint Managing Director, Executive Director
Ameya Chandavarkar
Chief Executive Officer - International Business, Executive Director · since 2021
Varsharani Katre
Compliance Officer, Company Secretary · since 2022
Nomita Chandavarkar
Non-Executive Non-Independent Director · since 2022
Uday Gurkar
Non-Executive Independent Chairman of the Board · since 2019
Vijay Bhatt
Non-Executive Independent Director · since 2023
Mahesh Bijlani
Non-Executive Independent Director · since 2019
Charuta Mandke
Non-Executive Independent Director · since 2024
Vijay Maniar
Non-Executive Independent Director · since 2022
IPO date
Aug 07, 1997
Employees
Domiciled in
IN
Incorporated in
IN
Legal address
FDC HOUSE, C-11 & 12, DALIA INDUSTRIAL ESTATE,OSHIWARA VILLAGE
OFF NEW LINK ROAD, ANDHERI (WEST)
ANDHERI
MUMBAI, MH 400053
IN
Headquarters
C - 3, SKYVISTAS,
NEAR VERSOVA POLICE STATION,
106A, J. P. ROAD,
ANDHERI (WEST),
MUMBAI, MH 400053
IN

Valuation

Title
INR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT